Literature DB >> 8218605

Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia.

P Mecocci1, R Ekman, L Parnetti, U Senin.   

Abstract

In order to evaluate their prevalence in senile dementias, serum titer of antibodies against histones and double stranded deoxyribonucleic acid (dsDNA) were measured by means of the ELISA test in patients suffering from vascular dementia (VD), presenile Alzheimer's disease (AD), and senile dementia of the Alzheimer's type (SDAT). Only three subjects out of 87 had dsDNA autoantibodies. On the contrary, VD and SDAT showed high titers of antibodies against histones when compared to healthy controls. A significant relationship was also found between antihistone serum titer and degree of dementia in AD. Results were not influenced by gender, age, or duration of illness. Presence of antihistone antibodies in dementias might reflect an alteration of membrane fluidity and integrity with leakage of nuclear immunogens or disturbances of immune functions, as frequently observed in dementia disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218605     DOI: 10.1016/0006-3223(93)90182-d

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

Review 1.  Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?

Authors:  Kristian P Doyle; Marion S Buckwalter
Journal:  Brain Behav Immun       Date:  2016-08-13       Impact factor: 7.217

2.  Extracellular histone H1 is neurotoxic and drives a pro-inflammatory response in microglia.

Authors:  Jonathan D Gilthorpe; Fazal Oozeer; Julia Nash; Margarita Calvo; David Lh Bennett; Andrew Lumsden; Adrian Pini
Journal:  F1000Res       Date:  2013-07-08

3.  Assessment of a combination of plasma anti-histone autoantibodies and PLA2/PE ratio as potential biomarkers to clinically predict autism spectrum disorders.

Authors:  Afaf El-Ansary; Mona Al-Onazi; Abdulrahman M Alhowikan; Mashael A Alghamdi; Laila Al-Ayadhi
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.